• Onco Vex III has met end points for melanoma

    Asked by CAS1 on Thursday, March 21, 2013

    Onco Vex III has met end points for melanoma

    UPDATED: Amgen scores PhIII success with BioVex virus against melanoma

    This data is very exciting for late stage melanoma. And a boost for immunotherapy

    1 Answer from the Community

    Help the community by answering this question:

    Create an account to post your answer Already have an account? Sign in!

    By using WhatNext, you agree to our User Agreement, and Privacy Policy


    Read and answer more lung cancer questions.  Also, don't forget to check out our Lung Cancer page.